Your browser has either disabled or does not support javascript. Javascript is required for full website experience.
Anchiano Therapeutics Ltd. ADR
ANCN
$
2.03
-13%
Wed January 13th, 2021
21:13
Press Releases
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Anchiano Therapeutics Ltd. - ANCN
PR Newswire
Tue December 15th, 2020
22:16
Press Releases
SHAREHOLDER ALERT: WeissLaw LLP Investigates Anchiano Therapeutics Ltd.
PR Newswire
Thu October 8th, 2020
16:00
Rating
Analysis
All You Need to Know About Anchiano Therapeutics Ltd. Sponsored ADR (ANCN) Rating Upgrade to Buy
Zacks
